Skip to search formSkip to main contentSkip to account menu

ICT-121 Dendritic Cell Vaccine

Known as: ICT-121, ICT-121 DC Vaccine, CD133 Peptides-pulsed Autologous DC Vaccine 
A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with purified peptides derived from the tumor-associated antigen (TAA… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Background: Breast carcinoma is a cancer with the highest number in women, Luminal B is the highest number of all types of… 
2017
2017
Standardization of stem cell therapy requires application of appropriate methods to evaluate safety and efficacy, including long… 
2017
2017
AIM This study was aimed to investigate the associations between single nucleotide polymorphisms of cancer stem cell marker genes… 
2016
2016
ObjectiveTo explore the association of functional single-nucleotide polymorphisms (SNPs) of CD133 with the risk of lung cancer… 
2014
2014
The tumour-specific ‘pre-metastatic niche’ has emerged as a potential driving force for tumour metastasis and has been confirmed… 
2014
2014
Cancer stem cells (CSCs) are known to be resistant to conventional chemotherapy and radiotherapy. Specific CSC targeting and… 
2013
2013
Abstract Purpose: Human hematopoietic stem cells (HSC) are thought to be a major target of radiation-induced leukemogenesis and… 
2012
2012
CD133, a marker which has been advocated to mark colorectal carcinoma "stem or tumour initiating cells" is amongst the frequently… 
2009
2009
CD133 has been postulated to be a colon cancer stem cell (CSCs) marker. Recent investigations suggest that CSCs might contribute…